These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6871151)

  • 1. Formation of covalent hybrids from amino-terminal and carboxy-terminal fragments of two ovomucoid third domains.
    Wieczorek M; Laskowski M
    Biochemistry; 1983 May; 22(11):2630-6. PubMed ID: 6871151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turkey ovomucoid third domain inhibits eight different serine proteinases of varied specificity on the same ...Leu18-Glu19 ... reactive site.
    Ardelt W; Laskowski M
    Biochemistry; 1985 Sep; 24(20):5313-20. PubMed ID: 3907700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Covalent hybrids of ovomucoid third domains made from one synthetic and one natural peptide chain.
    Wieczorek M; Park SJ; Laskowski M
    Biochem Biophys Res Commun; 1987 Apr; 144(1):499-504. PubMed ID: 3555488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of amino acid side chains to preformed cavities: interaction of serine proteinases with turkey ovomucoid third domains with coded and noncoded P1 residues.
    Bigler TL; Lu W; Park SJ; Tashiro M; Wieczorek M; Wynn R; Laskowski M
    Protein Sci; 1993 May; 2(5):786-99. PubMed ID: 8495199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermodynamics and kinetics of the hydrolysis and resynthesis of the reactive site peptide bond in turkey ovomucoid third domain by aspergillopeptidase B.
    Ardelt W; Laskowski M
    Acta Biochim Pol; 1983; 30(2):115-26. PubMed ID: 6346765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assignment of the 13C-NMR spectra of virgin and reactive-site modified turkey ovomucoid third domain.
    Robertson AD; Rhyu GI; Westler WM; Markley JL
    Biopolymers; 1990 Feb; 29(2):461-7. PubMed ID: 2331509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional NMR studies of Kazal proteinase inhibitors. 2. Sequence-specific assignments and secondary structure of reactive site modified turkey ovomucoid third domain.
    Rhyu GI; Markley JL
    Biochemistry; 1988 Apr; 27(7):2529-39. PubMed ID: 3382637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replacement of P1 Leu18 by Glu18 in the reactive site of turkey ovomucoid third domain converts it into a strong inhibitor of Glu-specific Streptomyces griseus proteinase (GluSGP).
    Komiyama T; Bigler TL; Yoshida N; Noda K; Laskowski M
    J Biol Chem; 1991 Jun; 266(17):10727-30. PubMed ID: 1674942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined X-ray crystal structures of the reactive site modified ovomucoid inhibitor third domains from silver pheasant (OMSVP3*) and from Japanese quail (OMJPQ3*).
    Musil D; Bode W; Huber R; Laskowski M; Lin TY; Ardelt W
    J Mol Biol; 1991 Aug; 220(3):739-55. PubMed ID: 1870129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal and molecular structures of the complex of alpha-chymotrypsin with its inhibitor turkey ovomucoid third domain at 1.8 A resolution.
    Fujinaga M; Sielecki AR; Read RJ; Ardelt W; Laskowski M; James MN
    J Mol Biol; 1987 May; 195(2):397-418. PubMed ID: 3477645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conformation of the third domain of turkey ovomucoid in solution. Structural analysis by two-dimensional Overhauser nuclear effect spectroscopy].
    Andrianov AM
    Mol Biol (Mosk); 1991; 25(5):1215-25. PubMed ID: 1753953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovomucoid third domains from 100 avian species: isolation, sequences, and hypervariability of enzyme-inhibitor contact residues.
    Laskowski M; Kato I; Ardelt W; Cook J; Denton A; Empie MW; Kohr WJ; Park SJ; Parks K; Schatzley BL
    Biochemistry; 1987 Jan; 26(1):202-21. PubMed ID: 3828298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR chemical shift mapping of the binding site of a protein proteinase inhibitor: changes in the (1)H, (13)C and (15)N NMR chemical shifts of turkey ovomucoid third domain upon binding to bovine chymotrypsin A(alpha).
    Song J; Markley JL
    J Mol Recognit; 2001; 14(3):166-71. PubMed ID: 11391787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
    Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
    Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chicken ovomucoid: determination of its amino acid sequence, determination of the trypsin reactive site, and preparation of all three of its domains.
    Kato I; Schrode J; Kohr WJ; Laskowski M
    Biochemistry; 1987 Jan; 26(1):193-201. PubMed ID: 3548816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arg15-Lys17-Arg18 turkey ovomucoid third domain inhibits human furin.
    Lu W; Zhang W; Molloy SS; Thomas G; Ryan K; Chiang Y; Anderson S; Laskowski M
    J Biol Chem; 1993 Jul; 268(20):14583-5. PubMed ID: 8325837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein binding chiral discrimination of HPLC stationary phases made with whole, fragmented, and third domain turkey ovomucoid.
    Pinkerton TC; Howe WJ; Ulrich EL; Comiskey JP; Haginaka J; Murashima T; Walkenhorst WF; Westler WM; Markley JL
    Anal Chem; 1995 Jul; 67(14):2354-67. PubMed ID: 8686875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of reactive-site hydrolyzed turkey ovomucoid third domain by nuclear magnetic resonance and distance geometry methods.
    Walkenhorst WF; Krezel AM; Rhyu GI; Markley JL
    J Mol Biol; 1994 Sep; 242(3):215-30. PubMed ID: 8089843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent structure of a low-molecular-mass protein, meleagrin, present in a turkey (Meleagris gallopavo) ovomucoid preparation.
    Odani S; Koide T; Ono T; Takahashi Y; Suzuki J
    J Biochem; 1989 Apr; 105(4):660-3. PubMed ID: 2760022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.